Figure 4
Calibration curves for predicting disease-free survival (DFS) and overall survival (OS) using the nomograms. (a) 8-month, 1, 2, and 3-year DFS in the training cohort; (b) 8-month, 1, 2, and 3-year DFS in the internal validation cohort; (c) 8-month, 1, 2, and 3-year DFS in the external validation cohort; (d) 8-month, 1, 2, and 3-year OS in the training cohort; (e) 8-month, 1, 2, and 3-year OS in the internal validation cohort; (f) 8-month, 1, 2, and 3-year OS in the external validation cohort.
